Evidence map›Paper›PMID 41173829›Full record

ArticleCell death & disease2025

Neuropathy-associated Tecpr2 mutation knock-in mice reveal endolysosomal loss of function phenotypes in neurons and microglia.

Debjani Bhattacharya, Patricia da Silva-Buttkus, Karsten Nalbach, Lizhen Cheng, Lillian Garrett, Martin Irmler, Georg Kislinger, Georg Werner, Ramona Rodde, Christoph Lengger and 12 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Debjani Bhattacharya *Munich Cluster for Systems Neurology (SyNergy), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Patricia da Silva-Buttkus *Institute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Karsten NalbachGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID http://orcid.org/0000-0002-3928-4026
Lizhen ChengMunich Cluster for Systems Neurology (SyNergy), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Lillian GarrettInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Martin IrmlerInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Georg KislingerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Georg WernerMetabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität München, Munich, Germany.
Ramona RoddeMetabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität München, Munich, Germany.
Christoph LenggerInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-2207-4153
Johannes BeckersInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Annemarie ZimprichInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Sabine M HölterInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0003-4878-5241
Valerie Gailus-DurnerInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Helmut FuchsInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Martin Hrabe de AngelisInstitute of Experimental Genetics and German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7898-2353
Benedikt WefersGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Wolfgang WurstGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Monika S BrillInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-5422-9175
Martina SchiffererGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Stefan F LichtenthalerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Christian BehrendsMunich Cluster for Systems Neurology (SyNergy), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. christian.behrends@mail03.med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-9184-7607

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 390857198Deutsche Forschungsgemeinschaft (German Research Foundation) 390857198, 259130777, 437166575EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 860035
6 · The paper itself

Abstract

Mutations in the gene encoding Tectonic β-propeller repeat-containing repeat protein 2 (TECPR2) cause hereditary sensory and autonomic neuropathy subtype 9 (HSAN9) which is a fatal neurodevelopmental and neurodegenerative disorder involving the sensory and peripheral nervous system. TECPR2 is ubiquitously expressed and linked to trafficking and sorting within the cell, however, its functional role remains poorly defined. Moreover, molecular insights into pathogenic mechanisms underlying HSAN9 are lacking. Here, we report a novel mouse model which harbors a HSAN9-associated nonsense mutation that causes loss of TECPR2 expression. Mice show altered gait, highly region-specific axonal dystrophy, and extensive local gliosis. The affected medulla area prominently features swollen axons filled with amorphous protein aggregates, glycogen granules, single and double membrane vesicles as well as aberrant organelles including ER and mitochondria whose proteome is distinctly altered. Despite the locally restricted pathology the neuronal demise is detectable in the cerebrospinal fluid and responded to by damage-associated microglia. However, their capacity to clear neuronal debris seems attenuated. Overall, neuronal and microglia phenotypes point to a dysfunctional endolysosomal system when TECPR2 is missing. This was confirmed in TECPR2 knockout cells and linked to TECPR2's interaction with the homotypic fusion and protein sorting (HOPS)-tethering complex. Collectively, we uncovered a role of TECPR2 in endolysosome maintenance which seems relevant for healthy neurons in a particular brain region.

Indexed as

EndosomesLysosomesMicrogliaMutationNerve Tissue ProteinsNeuronsAnimalsDisease Models, AnimalGene Knock-In TechniquesMicePhenotypeNerve Tissue Proteins

Identifiers

PMID41173829
PMCPMC12578842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.